http://www.unboundmedicine.com/medline/ebm/research/nebivololUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19892472/full_citation/Nebivolol_in_the_treatment_of_metabolic_syndrome:_Making_the_fat_more_brownish_Solak Y, Atalay H 
Nebivolol in the treatment of metabolic syndrome: Making the fat more brownish. [LETTER]
Med Hypotheses 2009 Nov 3.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19876413/full_citation/Reduced_Intimal_Hyperplasia_in_Rabbits_via_Medical_Therapy_after_Carotid_Venous_Bypass_Yucel S, Bahcivan M, Gol MK, et al. 
Reduced Intimal Hyperplasia in Rabbits via Medical Therapy after Carotid Venous Bypass. [Journal Article]
Tex Heart Inst J 2009; 36(5):387-92.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19843484/full_citation/Efficacy_and_tolerability_of_nebivolol_monotherapy_by_baseline_systolic_blood_pressure:_A_retrospective_analysis_of_pooled_data_from_two_multicenter_12_week_randomized_double_blind_placebo_controlled_parallel_group_dose_ranging_studies_in_patients_with_mild_to_moderate_essential_hypertension_Germino FW 
Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. [Journal Article]
Clin Ther 2009 Sep; 31(9):1946-56.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19819787/full_citation/Nebivolol_therapy_improves_endothelial_function_and_increases_exercise_tolerance_in_patients_with_cardiac_syndrome_X_Sen N, Tavil Y, Erdamar H, et al. 
Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. [JOURNAL ARTICLE]
Anadolu Kardiyol Derg 2009 Oct; 9(5):371-379.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19815121/full_citation/Nebivolol:_the_somewhat_different_beta_adrenergic_receptor_blocker_Münzel T, Gori T 
Nebivolol: the somewhat-different beta-adrenergic receptor blocker. [Journal Article, Review]
J Am Coll Cardiol 2009 Oct 13; 54(16):1491-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19809204/full_citation/Efficacy_of_nebivolol_on_flow_mediated_dilation_in_patients_with_slow_coronary_flow_Albayrak S, Ordu S, Yuksel H, et al. 
Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow. [Journal Article]
Int Heart J 2009 Sep; 50(5):545-53.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19789971/full_citation/Respiratory_Effects_of_beta_blocker_Therapy_in_Heart_Failure_Agostoni P, Palermo P, Contini M 
Respiratory Effects of beta-blocker Therapy in Heart Failure. [JOURNAL ARTICLE]
Cardiovasc Drugs Ther 2009 Sep 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19767556/full_citation/Could_Nebivolol_be_an_Alternative_Drug_for_the_Treatment_of_Diabetic_Foot_UlcersGulcan E 
Could Nebivolol be an Alternative Drug for the Treatment of Diabetic Foot Ulcers? [Journal Article]
J Am Podiatr Med Assoc 2009 Sep-Oct; 99(5):459.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19734185/full_citation/Regional_functions_of_the_left_ventricle_in_patients_with_coronary_slow_flow_and_the_effects_of_nebivolol_Gunes Y, Tuncer M, Guntekin U, et al. 
Regional functions of the left ventricle in patients with coronary slow flow and the effects of nebivolol. [JOURNAL ARTICLE]
Ther Adv Cardiovasc Dis 2009 Sep 4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19730416/full_citation/Loss_of_Arterial_and_Renal_Nitric_Oxide_Bioavailability_in_Hypertensive_Rats_With_Diabetes:_Effect_of_beta_Blockers_Preston Mason R, Kubant R, Jacob RF, et al. 
Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of beta-Blockers. [JOURNAL ARTICLE]
Am J Hypertens 2009 Sep 3.
Abstract | Full Citation